Chronic urticaria: advances in understanding of the disease and clinical management

L He, W Yi, X Huang, H Long, Q Lu - Clinical reviews in allergy & …, 2021 - Springer
Chronic urticaria (CU) is a common skin condition characterized by the recurrence of
wheals, with or without angioedema, which lasts for at least 6 weeks. Owing to its pruritus …

Rituximab and omalizumab for the treatment of bullous pemphigoid: a systematic review of the literature

N Kremer, I Snast, ES Cohen, E Hodak… - American Journal of …, 2019 - Springer
Background Bullous pemphigoid (BP) is the most common autoimmune blistering skin
disease worldwide. Systemic corticosteroids are considered the mainstay of therapy; …

Pathogenesis of solar urticaria: classic perspectives and emerging concepts

SM McSweeney, R Sarkany, H Fassihi… - Experimental …, 2022 - Wiley Online Library
Solar urticaria is a rare, immunologically mediated photodermatosis in which activation of
cutaneous mast cells is triggered by specific wavelengths of solar electromagnetic radiation …

Physical urticaria: Clinical features, pathogenesis, diagnostic work-up, and management

SM McSweeney, EAA Christou, M Maurer… - Journal of the American …, 2023 - Elsevier
Physical urticaria is a type of urticaria in which recurrent wheals and/or angioedema occur
following exposure of the skin to a physical stimulus. It is classified according to its triggers …

Two decades with omalizumab: what we still have to learn

C Incorvaia, M Mauro, E Makri, G Leo… - Biologics: Targets and …, 2018 - Taylor & Francis
From its availability for clinical use nearly two decades ago for severe asthma, omalizumab
has gained strong evidence of efficacy and safety in the treatment of severe asthma not …

Omalizumab for chronic urticaria in children younger than 12 years

T Al-Shaikhly, JA Rosenthal, AG Ayars… - Annals of Allergy …, 2019 - annallergy.org
Chronic urticaria (CU), defined by recurrent wheals, angioedema, or both lasting more than
6 weeks, is subclassified into chronic spontaneous urticaria (CSU) and inducible urticaria …

[HTML][HTML] Solar urticaria: an ambispective study in a long-term follow-up cohort with emphasis on therapeutic predictors and outcomes

D Pesqué, A Ciudad, E Andrades, S Dulce… - Acta Dermato …, 2024 - ncbi.nlm.nih.gov
Solar urticaria is a rare photodermatosis with several unknown pathogenic, clinical and
therapeutic aspects. This study analysed the clinical and therapeutic features of a long-term …

Ligelizumab for the treatment of chronic spontaneous urticaria

B Wedi - Expert opinion on biological therapy, 2020 - Taylor & Francis
Introduction Due to daily hives with itch, sleeplessness, and unforeseen development of
angioedema, chronic spontaneous urticaria significantly impairs quality of life, often for …

An overview of off-label use of humanized monoclonal antibodies in paediatrics

R Bernardini, G Toschi Vespasiani, A Giannetti - Medicina, 2022 - mdpi.com
In recent years, off-label and unlicensed drug use has extensively developed in the
paediatric population. For a long time, clinical trials in the paediatric population were …

Phototherapy in the evaluation and management of photodermatoses

AJ Jiang, HW Lim - Dermatologic clinics, 2020 - derm.theclinics.com
Diagnoses of photodermatoses can be challenging; patients can exhibit a wide variety of
symptoms and physical examination findings, and they can present during a disease-free …